To uncover how YTHDC2 suppresses bladder cancer, we conducted RNA sequencing, proteomics, and m6A methylated RNA immunoprecipitation (MeRIP) sequencing to identify the potential downstream effectors. Here, YTHDC2 is linked to urinary bladder carcinoma.